{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:00:11Z","timestamp":1788872411611,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"name":"PSP (Europe) Association Research Fellowship Grant"},{"name":"Wellcome Trust\/MRC Joint Call in Neurodegeneration"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.neurobiolaging.2013.04.011","type":"journal-article","created":{"date-parts":[[2013,5,9]],"date-time":"2013-05-09T06:31:36Z","timestamp":1368081096000},"page":"2889.e5-2889.e9","source":"Crossref","is-referenced-by-count":54,"title":["TDP-43 pathology in a patient carrying G2019S LRRK2\u00a0mutation and a novel p.Q124E MAPT"],"prefix":"10.1016","volume":"34","author":[{"given":"Helen","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanna","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Bandopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Holton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Xiromerisiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Houlden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Revesz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ana.21154","article-title":"TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease","volume":"61","author":"Amador-Ortiz","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00401-008-0480-1","article-title":"Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies","volume":"117","author":"Arai","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib4","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/01.WNL.0000158423.05224.7F","article-title":"The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs","volume":"64","author":"Burns","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib5","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1093\/hmg\/dds161","article-title":"Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases","volume":"21","author":"Coppola","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/mds.22096","article-title":"Clinical and pathological characteristics of patients with leucine-rich repeat kinase-2 mutations","volume":"24","author":"Covy","year":"2009","journal-title":"Move. Disord."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib7","doi-asserted-by":"crossref","first-page":"e31039","DOI":"10.1371\/journal.pone.0031039","article-title":"Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families","volume":"7","author":"Cruchaga","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00401-006-0178-1","article-title":"Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions","volume":"113","author":"Dachsel","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2990.2003.00463.x","article-title":"Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies","volume":"29","author":"de Silva","year":"2003","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib10","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1111\/j.1742-4658.2008.06707.x","article-title":"Emerging pathways in genetic Parkinson's disease: tangles, Lewy bodies and LRRK2","volume":"275","author":"Devine","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaneurol.2013.172","article-title":"Parkin disease: a clinicopathologic entity?","volume":"70","author":"Doherty","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jns.2008.02.010","article-title":"Screening for the LRRK2 G2019S and codon-1441 mutations in a pathological series of parkinsonian syndromes and frontotemporal lobar degeneration","volume":"270","author":"Gaig","year":"2008","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s12031-011-9641-0","article-title":"The age at motor symptoms onset in LRRK2-associated Parkinson's disease is affected by a variation in the MAPT locus: a possible interaction","volume":"46","author":"Gan-Or","year":"2012","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.20791","article-title":"Biochemical and pathological characterization of Lrrk2","volume":"59","author":"Giasson","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib15","first-page":"415","article-title":"A\u00a0common LRRK2 mutation in idiopathic Parkinson's disease","volume":"365","author":"Gilks","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib16","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/mds.23807","article-title":"Kin-cohort analysis of LRRK2-G2019S penetrance in Parkinson's disease","volume":"26","author":"Goldwurm","year":"2011","journal-title":"Move. Disord."},{"issue":"suppl 1","key":"10.1016\/j.neurobiolaging.2013.04.011_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000113460","article-title":"Autosomal dominant familial Parkinson disease: older onset of age, and good response to levodopa therapy","volume":"38","author":"Hasegawa","year":"1997","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.parkreldis.2008.07.010","article-title":"Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes","volume":"15","author":"Hasegawa","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib19","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/brain\/awm065","article-title":"TDP-43 is deposited in the Guam parkinsonism-dementia complex brains","volume":"130","author":"Hasegawa","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib20","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.neurobiolaging.2007.12.017","article-title":"The effect of age and the H1c MAPT haplotype on MAPT expression in human brain","volume":"30","author":"Hayesmoore","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging\u2013Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib24","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005072-199710000-00002","article-title":"Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease","volume":"56","author":"Hyman","year":"1997","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/alzrt137","article-title":"Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohort","volume":"4","author":"Jin","year":"2012","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib26","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1212\/01.wnl.0000304041.09418.b1","article-title":"Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype","volume":"70","author":"Josephs","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib27","doi-asserted-by":"crossref","first-page":"2231.e7","DOI":"10.1016\/j.neurobiolaging.2012.04.006","article-title":"The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features","volume":"33","author":"Kara","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib28","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1093\/brain\/awh667","article-title":"Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data","volume":"128","author":"Khan","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00401-012-1050-0","article-title":"Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant","volume":"125","author":"King","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1440-1789.2009.01085.x","article-title":"Abnormal TDP-43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system when identified in high and moderate stages of Alzheimer's disease","volume":"30","author":"King","year":"2010","journal-title":"Neuropathology"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00401-011-0811-5","article-title":"TDP-43 pathology may occur in the BRI2 gene-related dementias","volume":"121","author":"Lashley","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib32","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S1474-4422(10)70195-2","article-title":"TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"9","author":"Mackenzie","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/aws307","article-title":"The\u00a0spectrum of disease in chronic traumatic encephalopathy","volume":"136","author":"McKee","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2174\/187152709789541998","article-title":"Cross currents in protein misfolding disorders: interactions and therapy","volume":"8","author":"Morales","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib37","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000240220.33950.0c","article-title":"Parkinsonism, Lrrk2 G2019S, and tau neuropathology","volume":"67","author":"Rajput","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00401-008-0478-8","article-title":"LRRK2 and neurodegeneration","volume":"117","author":"Santpere","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib39","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/mds.23965","article-title":"High frequency and reduced penetrance of LRRK2 G2019S mutation among Parkinson's disease patients in Cantabria (Spain)","volume":"26","author":"Sierra","year":"2011","journal-title":"Move. Disord."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib40","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib41","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib42","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","article-title":"Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies","volume":"67","author":"Uryu","year":"2008","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000289232","article-title":"Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation","volume":"7","author":"Wider","year":"2010","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib44","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1212\/01.WNL.0000125015.06989.DB","article-title":"Autosomal dominant parkinsonism associated with variable synuclein and tau pathology","volume":"62","author":"Wszolek","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1353-8020(97)00013-8","article-title":"German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia\u2014longitudinal observations","volume":"3","author":"Wszolek","year":"1997","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib46","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/mds.24924","article-title":"Identical twins with Leucine rich repeat kinase type 2 mutations discordant for Parkinson's disease","volume":"27","author":"Xiromerisiou","year":"2012","journal-title":"Move. Disord."},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-010-0702-1","article-title":"Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy","volume":"120","author":"Yokota","year":"2010","journal-title":"Acta neuropathologica"},{"key":"10.1016\/j.neurobiolaging.2013.04.011_bib47","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013001644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013001644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:24:54Z","timestamp":1539649494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458013001644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0197458013001644"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.04.011","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}